Our Research centers
Where science thrives
Our new facility – in the centre of the Cambridge Biomedical Campus (CBC) – will be an open, welcoming and vibrant centre that will inspire our team and our partners to push the boundaries of scientific innovation.
Explore Cambridge
We believe the best way to meet today’s science challenges is to work openly and collaboratively with the world’s best scientists. Our home on the Cambridge Biomedical Campus enables us to partner with our academic, research and healthcare neighbours to make life-changing discoveries. Explore our digital viewing platform to discover a unique perspective on the power of partnerships.
About AstraZeneca in Cambridge
Our global headquarters moved to Cambridge in May 2016.
Since then, we have delivered over 130 collaborations with our academic, healthcare and research partners to make life-changing discoveries.
For example, our drug discovery scientists are working with Microsoft to use a cloud-based simulation tool that brings alive the millions of potential changes that make cancer cells multiply uncontrollably, to better understand the disease.
Similarly, scientists from MedImmune and Cancer Research UK are working together to discover and develop novel biologics to treat cancer. Together they are working on a novel target associated with leukaemia and recently started an exciting project looking at the best drug combinations to treat pancreatic cancer.
And a novel agreement is also in place that will give researchers from the University of Cambridge access to key compounds from our drugs pipeline.
Once completed, more than 2,000 AstraZeneca and MedImmune R&D science jobs will be on the CBC site, delivering more knowledge sharing, skills and expertise – and ultimately for pushing the boundaries of science.

Working side-by-side
The AstraZeneca Medical Research Council (AZ-MRC) Centre for Lead Discovery will be established in our new facility.
Bringing together world-class capabilities
Our new Cambridge site will bring together small molecule and biologics research and development activity across our main focus areas. It will also be home to a wide range of leading scientific capabilities, including:
Our inspiring scientists
Sharing our passion about what science can do
“I love working for MedImmune because of the passion our people have for great science, and our ability to turn this science into life-improving drugs.”
Strengthening our Cambridge presence
We are building on our proud Medimmune heritage in Cambridge. More than two thousand AstraZeneca and MedImmune employees are already based in the city and working to build strong connections within the local scientific community.

A proud Cambridge heritage: MedImmune in the UK
With over 550 employees, MedImmune’s team at Granta Park is focused on the research and early development of our biologics portfolio. MedImmune has built on the local legacy of Cambridge Antibody Technology (CAT) – acquired by AstraZeneca and integrated with MedImmune in 2007 – where three marketed products (Humira, Benlysta and raxibacumab) were invented. MedImmune Cambridge has strong collaborative links with numerous academics, researchers, foundations and neighbouring companies in the largest biotech cluster in Europe and has an active outreach programme within the local community.
Our current Cambridge facilities
High quality lab and office facilities to accommodate our growing presence in the city.
Open for innovation
Combining the science in our labs with the great science happening within the Cambridge scientific community will enable us to push the boundaries of science further than ever before.

Working with Horizon Discovery to search for novel, personalised cancer therapies
Collaboration and license agreement to explore Horizon’s first-in-class kinase target programme, as a means of developing novel therapies for multiple cancer types.

Our community involvement
With a number of PhD programmes with the University of Cambridge through to our ongoing commitment to STEM programmes in the local community, we are passionate about finding new ways to ensure we support, develop and inspire the next generation of Cambridge scientists.